Jamila Iqbal is an early career researcher at the Griffith Institute for Drug Discovery (GRIDD), specializing in cell biology. Her primary research focus is on utilizing olfactory stem cells obtained from patients to understand the underlying mechanisms of neurological diseases and to develop treatments that can reverse the disease phenotype. Jamila is currently working on creating image-based assays that can identify disease-relevant phenotypes in patient-derived cells, which can then be used as biomarkers for drug screening purposes. During her PhD, Jamila's research was focused on small molecule probes that could provide insights into the mechanisms of neurodegeneration in Parkinson's disease. Using cytological profiling, she was able to distinguish between the idiopathic and genetic forms of Parkinson's disease and healthy individuals by investigating cellular and subcellular phenotypes. Currently, Jamila is researching cellular biomarkers for schizophrenia and Hereditary Spastic Paraplegia.